Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Setmelanotide in POMC, LEPR, or PCSK1 Deficiency
NCT02507492Phase 2Unknown
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jan 2015
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
A Phase 2 trial of setmelanotide in obesity, sponsored by Charité – Universitätsmedizin Berlin. Status: unknown.
02
Drugs
setmelanotide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02507492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02507492.